Although PD-L1, TMB, and dMMR/MSI-H were detected at low levels in tumor tissue, this patient still benefited from combined treatment with immune checkpoint inhibitors and lenvatinib and regained disease control. The gene discussed is CD274; the disease is neoplasm.